chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Carbon dioxide decreased, Chest X-ray abnormal, Computerised tomogram head normal, Culture urine
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Decreased appetite, Endotracheal intubation, Extubation, Fall
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Fraction of inspired oxygen, Fungal test positive, Hypophosphataemia, Hypotension
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Leukocytosis, Lung infiltration, Mechanical ventilation, PCO2 decreased
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: PO2 decreased, Positive airway pressure therapy, Positive end-expiratory pressure, Post procedural hypotension, Pyrexia
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory disorder, Respiratory failure, SARS-CoV-2 test positive, Serum ferritin increased, Shift to the left
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Sinus rhythm, Sputum culture positive, Transaminases, Urinary tract infection, Urine analysis abnormal
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Narrative: HPI: Patient presented to the ED on 12/7/2021 with a chief complaint of weakness. Son stated Patient fell at home earlier that day. Son also reported decreased appetite and fever at home. In triage, Patient was afebrile and hemodynamically stable. SpO2 was 93% on Room Air. Labs in ED revealed leukocytosis with left shift (WBC 14.39, bands 5), elevated BUN (34mg/dL), depressed serum bicarb (CO2 20.4mmol/L, AG 18.4), hypophosphatemia (Mg 2.3mg/dL), elevated T. bili (2.4mg/dL), normal transaminases, elevated CRP (19.65), positive d-dimer (3.5), positive lactate (4.2), and elevated ferritin (886.1). UA was suggestive of UTI. COVID-19 test was POSITIVE. ABG on room air revealed hypoxic respiratory failure (pH 7.5, pCO2 27 , pO2 37). Blood and urine cultures were obtained. CXR revealed interval bilateral interstitial infiltrates. Patient was given acetaminophen 1000mg IV x 1, ceftriaxone 1g IV x 1, and 1L NS in the ED. He was admitted to ICU fur further care. Update of Present Illness: 12/13/2021 - Patient was placed on HFNC on admission. Dexamethasone and remdesivir were initiated upon admission to the ICU. Ceftriaxone was continue. Azithromycin and linezolid were initiated. Tocilizumab was given. Linezolid was discontinued on 12/8/2021. Respiratory status declined. Patient was transitioned to BIPAP on 12/10/2021 and ultimately was intubated that AM. Patient develop hypotension post-intubation and pressors were initiated. This AM, Patient remains sedated and intubated. Norepinephrine continues. 12/20/2021 - Patient remains sedated and intubated this AM. FiO2 and PEEP requirements decreased over the weekend. Patient developed leukocytosis on 12/19/2021. Patient was pan-cultured. Piperacillin/tazobactam and vancomycin. Norepinephrine was resumed last night at low dose. 12/21/2021 - Low dose norepinephrine continues. Sputum growing a mold and a yeast on preliminary report. 12/22/2021 - Voriconazole was initiated yesterday due to sputum culture. No acute events noted overnight. Norepinephrine requirements have slightly increased over the past 24 hours. Ventilator settings stable over the past 24 hours. 12/23/2021 - CT angiogram obtained this AM and was positive for PE. CT head was negative for acute intracranial findings. Patient develop atrial fibrillation with RVR and hypotension this afternoon. Amiodarone protocol initiated. Art line placed. Digoxin given. 12/27/2021 - Micafungin was initiated on 12/24/2021. Repeat sputum culture from 12/23 is also growing an unidentified fungus. Micafungin was discontinued and amphotericin B was initiated on 12/25/2021. Vasopressin initiated on 12/25/2021. Patient remains vasopressor dependent this AM. PEEP and FiO2 requirements are high. Patient is in NSR this AM. Patient's family came in for visit and elected to withdraw care. Patient died shortly after terminal extubation.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Gastric ulcer, Haemoglobin decreased, Headache, Iron deficiency anaemia, Laboratory test abnormal
Clinical narrative: Patient's COVID-19 vaccinations: 12/28/2020, 1/20/2021, and  9/9/2021. Patient was seen on 2 18 2021 stating he has been told his skin was  looking "yellowish" and pale, therefore labs were drawn. Patient had a critical  lab value of Hgb 3.8 and referred to the ED for transfusion. Per H&P, patient  endorses headaches that began after he received his second COVID-19 vaccine.  Low hgb related to acute on chronic severe iron deficiency anemia, most likely  secondary to cameron lesion per EGD 2/22/2021.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Oesophagogastroduodenoscopy abnormal, Pallor, Transfusion, Yellow skin
Clinical narrative: Patient's COVID-19 vaccinations: 12/28/2020, 1/20/2021, and  9/9/2021. Patient was seen on 2 18 2021 stating he has been told his skin was  looking "yellowish" and pale, therefore labs were drawn. Patient had a critical  lab value of Hgb 3.8 and referred to the ED for transfusion. Per H&P, patient  endorses headaches that began after he received his second COVID-19 vaccine.  Low hgb related to acute on chronic severe iron deficiency anemia, most likely  secondary to cameron lesion per EGD 2/22/2021.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient received one dose of covid vaccine. Passed 5 days later. Unclear if she had any medical history that would cause death or if this is related to covid vaccination. Reporting per Regulatory Authority instructions.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Heart rate increased
Clinical narrative: Severe Headache, High Heart Rate, Fever, Night Sweats, Body Aches, Rigors, joint Pain, Muscle Aches, Fatigue
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Night sweats, Pain, Pyrexia
Clinical narrative: Severe Headache, High Heart Rate, Fever, Night Sweats, Body Aches, Rigors, joint Pain, Muscle Aches, Fatigue
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac arrest, Catheterisation cardiac abnormal, Condition aggravated, Myocardial infarction
Clinical narrative: Severe heart attack - 3 times heart arrest
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Myocardial infarction, Stent placement
Clinical narrative: Narrative: Pt was an 82 YO male with PMH of aortic valve regurgitation, CHF, bladder cancer, recurrent pneumonia, cognitive impairment, DM2, HLD, CAD, HTN, PD, and depression was admitted to hospital for heart attack and passed away during attempted stent placement.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Herpes zoster, Rash papular
Clinical narrative: Shingles (herpes zoster) on back. Small patch of raised blisters. Treated with anti-viral medication. Cleared-up after course of treatment. Patient had shingles 20 years ago.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Haematuria, Headache, Impaired quality of life, Muscle spasms
Clinical narrative: Debilitating nausea, headache, muscle aches, feverish feeling: 12-96 hrs after injection, resulved  Tinnitus (severe, impacting quality of life and sleep):  began 2-3 days after injection, ongoing  Severe leg cramps:  6-7 days after injection, resolved  Hematuria:  8 days after injection, resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia, Sleep disorder, Tinnitus
Clinical narrative: Debilitating nausea, headache, muscle aches, feverish feeling: 12-96 hrs after injection, resulved  Tinnitus (severe, impacting quality of life and sleep):  began 2-3 days after injection, ongoing  Severe leg cramps:  6-7 days after injection, resolved  Hematuria:  8 days after injection, resolved
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis
Clinical narrative: Debilitating nausea, headache, muscle aches, feverish feeling: 12-96 hrs after injection, resulved  Tinnitus (severe, impacting quality of life and sleep):  began 2-3 days after injection, ongoing  Severe leg cramps:  6-7 days after injection, resolved  Hematuria:  8 days after injection, resolved
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Appendicectomy, Appendicitis, Nausea, Ultrasound abdomen abnormal
Clinical narrative: Within 7 hours of my son receiving the Pfizer booster shot on December 22, 2021, he started to get a bad stomachache and 3 hours later he experienced severe vomiting and nausea.  This lasted into the following day.  By 10pm December 23, 2021 we took him to the emergency room where they preformed an ultra-sound and determined he had appendicitis.    They performed an emergency appendectomy on December 24th, 2021 at 9:30am.  There were no complications and he is recovering well.  Prior to this incident, he was a very healthy 16 year old athlete.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Within 7 hours of my son receiving the Pfizer booster shot on December 22, 2021, he started to get a bad stomachache and 3 hours later he experienced severe vomiting and nausea.  This lasted into the following day.  By 10pm December 23, 2021 we took him to the emergency room where they preformed an ultra-sound and determined he had appendicitis.    They performed an emergency appendectomy on December 24th, 2021 at 9:30am.  There were no complications and he is recovering well.  Prior to this incident, he was a very healthy 16 year old athlete.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Developed chronic hives%
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mechanical urticaria, Pain in extremity, Pyrexia
Clinical narrative: Developed chronic hives%
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation irregular
Clinical narrative: Irregular menstrual cycle - much earlier than normal period start date, (early by at least two weeks) compared to regular menstrual cycle start dates.
Age: 36.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Abnormal behaviour, Agitation, Blood lactic acid, Chest X-ray, Coagulation test
Clinical narrative: Seizures  I was found wandering naked outside the house at 5:40-6 AM.  I was let in the home and said I had to pee repeatedly, going to the bathroom 3-4 times in about 10 minutes.  My mother in law called my wife and and she brought me to the bedroom.  She saw I was confused and the room I was sleeping in was in disarray.  She was concerned but I thought I had probably been sleepwalking.  She is a night nurse so she went to sleep but stayed with me due to the strange occurrence. We typically sleep apart right now due to the covid surge.  Around 1245 PM my wife awoke to me seizing.  I had a tonic clonic seizure.  I was foaming into my CPAP mask and wet the bed with urine.  My wife pulled off my CPAP and ran into the house to alert her parents to call 911.  When she returned 20-30 sec later I had fallen onto the floor and knocked my bed to the side.  She held me to the side and I was still seizing when EMS arrived.  I did not respond to sternal rub.  EMS brought me to the hospital and I needed to be sedated and restrained as I was extremely confused and agitated after the event.  They tried versed x2 and finally ketamine IM to sedate me.    I received fluids, IV antibiotics, IV keppra, IV tylenol and IV muscle relaxers.    I know I had another unwitnessed seizure earlier that morning due to the pattern of disarray in the room after the second witnessed seizure.  I had fallen out of the bed both times.
Age: 36.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Computerised tomogram head, Confusional state, Echocardiogram, Electroencephalogram, Fall
Clinical narrative: Seizures  I was found wandering naked outside the house at 5:40-6 AM.  I was let in the home and said I had to pee repeatedly, going to the bathroom 3-4 times in about 10 minutes.  My mother in law called my wife and and she brought me to the bedroom.  She saw I was confused and the room I was sleeping in was in disarray.  She was concerned but I thought I had probably been sleepwalking.  She is a night nurse so she went to sleep but stayed with me due to the strange occurrence. We typically sleep apart right now due to the covid surge.  Around 1245 PM my wife awoke to me seizing.  I had a tonic clonic seizure.  I was foaming into my CPAP mask and wet the bed with urine.  My wife pulled off my CPAP and ran into the house to alert her parents to call 911.  When she returned 20-30 sec later I had fallen onto the floor and knocked my bed to the side.  She held me to the side and I was still seizing when EMS arrived.  I did not respond to sternal rub.  EMS brought me to the hospital and I needed to be sedated and restrained as I was extremely confused and agitated after the event.  They tried versed x2 and finally ketamine IM to sedate me.    I received fluids, IV antibiotics, IV keppra, IV tylenol and IV muscle relaxers.    I know I had another unwitnessed seizure earlier that morning due to the pattern of disarray in the room after the second witnessed seizure.  I had fallen out of the bed both times.
Age: 36.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Foaming at mouth, Full blood count, Generalised tonic-clonic seizure, Laboratory test, Magnetic resonance imaging head
Clinical narrative: Seizures  I was found wandering naked outside the house at 5:40-6 AM.  I was let in the home and said I had to pee repeatedly, going to the bathroom 3-4 times in about 10 minutes.  My mother in law called my wife and and she brought me to the bedroom.  She saw I was confused and the room I was sleeping in was in disarray.  She was concerned but I thought I had probably been sleepwalking.  She is a night nurse so she went to sleep but stayed with me due to the strange occurrence. We typically sleep apart right now due to the covid surge.  Around 1245 PM my wife awoke to me seizing.  I had a tonic clonic seizure.  I was foaming into my CPAP mask and wet the bed with urine.  My wife pulled off my CPAP and ran into the house to alert her parents to call 911.  When she returned 20-30 sec later I had fallen onto the floor and knocked my bed to the side.  She held me to the side and I was still seizing when EMS arrived.  I did not respond to sternal rub.  EMS brought me to the hospital and I needed to be sedated and restrained as I was extremely confused and agitated after the event.  They tried versed x2 and finally ketamine IM to sedate me.    I received fluids, IV antibiotics, IV keppra, IV tylenol and IV muscle relaxers.    I know I had another unwitnessed seizure earlier that morning due to the pattern of disarray in the room after the second witnessed seizure.  I had fallen out of the bed both times.
Age: 36.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Magnetic resonance imaging spinal, Patient elopement, Patient restraint, Pollakiuria, Seizure
Clinical narrative: Seizures  I was found wandering naked outside the house at 5:40-6 AM.  I was let in the home and said I had to pee repeatedly, going to the bathroom 3-4 times in about 10 minutes.  My mother in law called my wife and and she brought me to the bedroom.  She saw I was confused and the room I was sleeping in was in disarray.  She was concerned but I thought I had probably been sleepwalking.  She is a night nurse so she went to sleep but stayed with me due to the strange occurrence. We typically sleep apart right now due to the covid surge.  Around 1245 PM my wife awoke to me seizing.  I had a tonic clonic seizure.  I was foaming into my CPAP mask and wet the bed with urine.  My wife pulled off my CPAP and ran into the house to alert her parents to call 911.  When she returned 20-30 sec later I had fallen onto the floor and knocked my bed to the side.  She held me to the side and I was still seizing when EMS arrived.  I did not respond to sternal rub.  EMS brought me to the hospital and I needed to be sedated and restrained as I was extremely confused and agitated after the event.  They tried versed x2 and finally ketamine IM to sedate me.    I received fluids, IV antibiotics, IV keppra, IV tylenol and IV muscle relaxers.    I know I had another unwitnessed seizure earlier that morning due to the pattern of disarray in the room after the second witnessed seizure.  I had fallen out of the bed both times.
Age: 36.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Troponin increased, Urinary incontinence, Urine analysis
Clinical narrative: Seizures  I was found wandering naked outside the house at 5:40-6 AM.  I was let in the home and said I had to pee repeatedly, going to the bathroom 3-4 times in about 10 minutes.  My mother in law called my wife and and she brought me to the bedroom.  She saw I was confused and the room I was sleeping in was in disarray.  She was concerned but I thought I had probably been sleepwalking.  She is a night nurse so she went to sleep but stayed with me due to the strange occurrence. We typically sleep apart right now due to the covid surge.  Around 1245 PM my wife awoke to me seizing.  I had a tonic clonic seizure.  I was foaming into my CPAP mask and wet the bed with urine.  My wife pulled off my CPAP and ran into the house to alert her parents to call 911.  When she returned 20-30 sec later I had fallen onto the floor and knocked my bed to the side.  She held me to the side and I was still seizing when EMS arrived.  I did not respond to sternal rub.  EMS brought me to the hospital and I needed to be sedated and restrained as I was extremely confused and agitated after the event.  They tried versed x2 and finally ketamine IM to sedate me.    I received fluids, IV antibiotics, IV keppra, IV tylenol and IV muscle relaxers.    I know I had another unwitnessed seizure earlier that morning due to the pattern of disarray in the room after the second witnessed seizure.  I had fallen out of the bed both times.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Dry eye, Eyelid function disorder, Facial paralysis, Hypoaesthesia
Clinical narrative: I went to sleep feeling nothing out the blue I looked and felt the same. No more than an hour I woke up to the right side of my face dropping, swelled, no feeling, and my right eye was dry and droopy as well. It looked as if I had a stroke. I went to the emergency room and they diagnosed me with Bell?s Palsy and told me it was caused by the booster shot. I was given Prednisone, GenTeal Tears, and Refresh Liquigel.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Swelling face
Clinical narrative: I went to sleep feeling nothing out the blue I looked and felt the same. No more than an hour I woke up to the right side of my face dropping, swelled, no feeling, and my right eye was dry and droopy as well. It looked as if I had a stroke. I went to the emergency room and they diagnosed me with Bell?s Palsy and told me it was caused by the booster shot. I was given Prednisone, GenTeal Tears, and Refresh Liquigel.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria chronic
Clinical narrative: Chronic spontaneous urticaria, chronic itching
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased
Clinical narrative: Patient reported feeling dizzy and short of breath 15 minutes after vaccine was given while sitting in the observation area. SHe was placed in an anti gravity chair, given a bottle of water, and vitals were taken. Her HR was slightly increased HR: 101, BP: 133/77, O2: 98%. Patient has a history of panic and anxiety disorder. She stated she felt better at 12:10 PM. She was alert and oriented times 4 the entire time while in the observation area. Vitals were taken at 12:10 PM and were as follows: HR: 97, BP: 119/80, and O2: 98%.  She left the observation area with a steady gait and was advised to follow up her primary care provider. She did not have any reaction with her first 2 doses of Moderna.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache: started after receiving COVID vaccine (first dose) on 12/27/2021, Was seen on 1/1/2022 with persistent headache.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Pruritus, Throat tightness, Urticaria
Clinical narrative: All over body hives 11 days from Moderna booster. Started at groin, head, and collarbone. Also, painful chest tightening and closing throat feeling during hive episodes. Hives come and go each day. Incredible itching on welts.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein normal, Chest discomfort, Dyspnoea, Extrasystoles, Influenza A virus test negative
Clinical narrative: Chief complaint of "feels like my heart is skipping a beat", palpitations, and some mild chest tightness. Intermittent shortness of breath. No fever or cough. No treatments were required, but cardiology recommended observation admission. No beds were available locally or state-wide. The patient opted to leave against the provider's advice and wished to follow up on an outpatient basis.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza B virus test, Palpitations, Respiratory syncytial virus test negative, SARS-CoV-2 test negative, Troponin T normal
Clinical narrative: Chief complaint of "feels like my heart is skipping a beat", palpitations, and some mild chest tightness. Intermittent shortness of breath. No fever or cough. No treatments were required, but cardiology recommended observation admission. No beds were available locally or state-wide. The patient opted to leave against the provider's advice and wished to follow up on an outpatient basis.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Chief complaint of "feels like my heart is skipping a beat", palpitations, and some mild chest tightness. Intermittent shortness of breath. No fever or cough. No treatments were required, but cardiology recommended observation admission. No beds were available locally or state-wide. The patient opted to leave against the provider's advice and wished to follow up on an outpatient basis.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Joint stiffness, Malaise, Pruritus
Clinical narrative: I had a headache and malaise starting 12 hours after my shot. This shot was shot 3, a booster shot. I received my 2nd dose on 6/12/21. The adverse events I am reporting started three days after my third shot, 12/26/21. I suddenly had red, itchy hives covering my ankles, and portions of both legs. The next night, in addition to the leg hives, I now had hives on both arms. My knees were also stiff starting that night, limiting the motion range.  Starting Friday 12/31, I had some hives on small portions of my torso.  I have not, as of yet, had trouble breathing, rapid heartbeat, or a swollen face. The joint stiffness has improved. I do not suffer from seasonal allergies, so I did not have any allergy medicine on hand.  I was snowed in for several days following 12/26-I could not get to a store until 12/31 due to the snow and my work schedules. I had some anti itch cream with menthol, which sometimes provided temporary relief for the itching.  I started taking diphenhydramine (25 mg each pill) on 12/31. It seems to have relieved the emergence of hives and most of the flaring up of them, but they have not gone away yet.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: I had a headache and malaise starting 12 hours after my shot. This shot was shot 3, a booster shot. I received my 2nd dose on 6/12/21. The adverse events I am reporting started three days after my third shot, 12/26/21. I suddenly had red, itchy hives covering my ankles, and portions of both legs. The next night, in addition to the leg hives, I now had hives on both arms. My knees were also stiff starting that night, limiting the motion range.  Starting Friday 12/31, I had some hives on small portions of my torso.  I have not, as of yet, had trouble breathing, rapid heartbeat, or a swollen face. The joint stiffness has improved. I do not suffer from seasonal allergies, so I did not have any allergy medicine on hand.  I was snowed in for several days following 12/26-I could not get to a store until 12/31 due to the snow and my work schedules. I had some anti itch cream with menthol, which sometimes provided temporary relief for the itching.  I started taking diphenhydramine (25 mg each pill) on 12/31. It seems to have relieved the emergence of hives and most of the flaring up of them, but they have not gone away yet.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Condition aggravated, Dizziness, Ear discomfort, Feeling abnormal
Clinical narrative: A few hours after my booster, I experienced unsteadiness/dizziness/ear popping.   Daily I still have very  feelings of unsteadiness, a high pitch (tinnitis), but just briefly a few times a day.  I tried flonase, took a course of prednisone and while the feelings of unsteadiness have greatly improved, I still have tinnitus  and  Am still not 100%?
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: A few hours after my booster, I experienced unsteadiness/dizziness/ear popping.   Daily I still have very  feelings of unsteadiness, a high pitch (tinnitis), but just briefly a few times a day.  I tried flonase, took a course of prednisone and while the feelings of unsteadiness have greatly improved, I still have tinnitus  and  Am still not 100%?
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction, Injection site pain, Injection site rash, Rash, Rash erythematous
Clinical narrative: About 120 days after I got my second dose of Pfizer-BioNTech COVID-19 Vaccine (Comirnaty®), a rash developed on the outside of my upper right arm at the injection site where I got the first and second Pfizer vaccine shots. After that rash faded away, other rashes subsequently appeared in the following consecutive order: inside my right arm,,,under my left wrist; and inside my left arm. I got my second dose of the Pfizer vaccine in April 2021 and the rashes started appearing in August 2021 through September 2021. The rashes were reddish in appearance, were initially slightly itchy, and had a raised bump in the center similar to that of an insect bite. As the rashes started to fade, the centers of the rashes became encrusted/scabbed over, until they eventually faded away. It took approximately three weeks for each of the rashes to fade away. Presently, the rashes have all faded away, but my upper right arm is still slightly sore (prior to the rashes developing, the only other time that my upper right arm was sore was immediately following the initial Pfizer vaccine shots). I wish to refrain from speculating, but each of the rashes appears to have formed over places where I had received past injections/shots/IVs. Please note that I took pictures of several of the rashes that I am willing to submit upon your request.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash papular, Rash pruritic, Scab
Clinical narrative: About 120 days after I got my second dose of Pfizer-BioNTech COVID-19 Vaccine (Comirnaty®), a rash developed on the outside of my upper right arm at the injection site where I got the first and second Pfizer vaccine shots. After that rash faded away, other rashes subsequently appeared in the following consecutive order: inside my right arm,,,under my left wrist; and inside my left arm. I got my second dose of the Pfizer vaccine in April 2021 and the rashes started appearing in August 2021 through September 2021. The rashes were reddish in appearance, were initially slightly itchy, and had a raised bump in the center similar to that of an insect bite. As the rashes started to fade, the centers of the rashes became encrusted/scabbed over, until they eventually faded away. It took approximately three weeks for each of the rashes to fade away. Presently, the rashes have all faded away, but my upper right arm is still slightly sore (prior to the rashes developing, the only other time that my upper right arm was sore was immediately following the initial Pfizer vaccine shots). I wish to refrain from speculating, but each of the rashes appears to have formed over places where I had received past injections/shots/IVs. Please note that I took pictures of several of the rashes that I am willing to submit upon your request.